The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.25
Bid: 24.00
Ask: 24.50
Change: 0.00 (0.00%)
Spread: 0.50 (2.083%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 24.25
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Cyan, Aer Lingus, Mobile Tornado ...

Thu, 07th Jun 2012 13:59

Cyan Holdings, the wireless solutions company, has revealed that three more Cyan partners have received requests from the Tamil Nadu Electricity Board (TNEB) Automatic Meter Reading tender to proceed with installation and commissioning of 500 unit pilots within the next 25 days. The news follows Cyan's announcement at the end of May that the first Cyan metering partner in India had received a formal request from the TNEB. Airline company Aer Lingus Group has said that its flown passenger load factor in May 2012 increased by 2.9 percentage points on May 2011 to 76.2%. Short haul flown load factor was 73.8%, an increase of 0.9 points on May 2011, with capacity decreasing by 1.6%. Long haul flown load factor was 81.5%, a year-on-year (y/y) increase of 7.4 points, with capacity increasing by 0.5%. The company's flown passengers in May totalled 882,000, a y/y increase of 0.1% compared. Short haul flown passengers in May 2012 were 793,000, a y/y decrease of 1.1%, while long haul flown passengers in May 2012 were 89,000, an increase of 12.7% on May 2011. Aer Lingus Regional's total flown passenger numbers in May 2012 were 88,000, an increase of 33.3% compared to May 2011. Mobile Tornado Group, a provider of instant communication mobile applications to the enterprise market, posted a rise in revenues from £1.4m to £2.0m, while pre-tax loses narrowed to £1.2m (2010: £1.6m). The cost of sales doubled to £0.7m, while basic and diluted losses per share came in at 0.59p, compared to 0.85p the previous year. The company achieved increased sales activity during the year, up 43%, and believes that market within which it operates is increasingly receptive to the proposition it has developed. ANGLE, a technology commercialisation company, has said that its partner, ORIGIO, has received a bid from Cooper Companies, which values ORIGIO at $189m, including debt. Directors and shareholders owning a total of 46% in the company have signed irrevocable undertakings to accept the Cooper offer. The offer represents a 73% premium to the closing price of the shares on June 1st. Cooper has said the combined business will be ranked number one in the IVF market with a 39% market share. If the offer is completed, ORIGIO will continue under the same executive management team and name, operating as an indirect wholly-owned subsidiary of Cooper.Sareum Holdings has conditionally raised £25,000 (before expenses) after placing just over 2.9m shares at 0.85p each. The placing follows a placing made on Wednesday, which raised £0.23m. The company believes that both placings offer the most effective way of providing capital to accelerate its drug discovery programme and to provide working capital for the company. It is expected that the shares will begin trading on June 11th. The company now has around 1.5bn shares in issue.
More News
10 Mar 2016 13:00

Sareum Holdings Unaware Of Reason For Share Price Jump

Read more
24 Feb 2016 12:25

Sareum inches closer to drug breakthrough

(ShareCast News) - Sareum Holdings was still running on the smell of an oily rag in its interim report on Wednesday, but the company was confident it was heading towards a breakthrough in its durgs under development. The AIM-traded cancer drug discovery and development business saw no revenue during

Read more
24 Feb 2016 09:40

Sareum Holdings Reports Narrowed Loss As It Focuses On CHK1 Trials

Read more
1 Feb 2016 09:14

Sareum Submits Clinical Trial Applications For Cancer Drug Candidate

Read more
15 Dec 2015 08:40

Sareum Clinical Trials Application For Cancer Drug Coming In January

Read more
8 Dec 2015 15:58

AGM, EGM Calendar - Week Ahead

Read more
26 Oct 2015 08:59

Sareum Holdings Loss Widens As It Moves Towards Clinical Trials

Read more
15 Sep 2015 08:06

Sareum Holdings Gets US, European Patents For Aurora+FLT3 Inhibitors

Read more
23 Jul 2015 09:06

Sareum Says Journal Reports On Lung And Pancreatic Cancer Treatment

Read more
17 Jun 2015 07:56

Sareum Wins Funding To Investigate Treatment Of Adolescent Leukaemia

Read more
28 May 2015 11:26

LONDON MIDDAY BRIEFING: Corporate Sponsors Join Backlash Against FIFA

Read more
28 May 2015 10:35

WINNERS & LOSERS: Sports Direct Expects Earnings To Beat Forecasts

Read more
28 May 2015 07:13

Sareum Raises GBP1.4 Million Via Discounted Share Placing (ALLISS)

Read more
12 May 2015 12:28

LONDON MIDDAY BRIEFING: EasyJet Outlook Hits Turbulence

Read more
12 May 2015 10:36

WINNERS & LOSERS: easyJet Slides As Analysts Set To Cut Forecasts

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.